Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N6CS
|
|||
| Former ID |
DCL000111
|
|||
| Drug Name |
FG-2216
|
|||
| Indication | Kidney disease [ICD-11: GC2Z] | Phase 2 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H9ClN2O4
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)C(=C(N=C2Cl)C(=O)NCC(=O)O)O
|
|||
| InChI |
1S/C12H9ClN2O4/c13-11-7-4-2-1-3-6(7)10(18)9(15-11)12(19)14-5-8(16)17/h1-4,18H,5H2,(H,14,19)(H,16,17)
|
|||
| InChIKey |
OUQVKRKGTAUJQA-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 223387-75-5
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | HIF-prolyl hydroxylase (HPH) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018242) | |||
| REF 2 | Inhibition of Prolyl Hydroxylases Increases Erythropoietin Production in ESRD | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.